Investing

Atossa Therapeutics : ATOS

ATOS

Stock Data

$2.36

$0.06 (2.48%)

Asset Type

Common Stock

Exchange

NASDAQ

Currency

USD

Country

USA

Sector

HEALTHCARE

Industry

BIOTECHNOLOGY

Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, discovers and develops drugs in the areas of oncology and infectious diseases. The company is headquartered in Seattle, Washington.

All Atossa Therapeutics Articles

1 Article

Chris Lange | Jul 6, 2021 at 10:05 AM EDT

Tuesday’s Early Meme Stock Action Sees Clover Health Tumbling, AMC Higher and More

The WallStreetBets community has been a resounding force in the market since January causing many investors to reevaluate their positions.…